Login / Signup

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases.

Luis Horacio Gutiérrez-GonzálezSelma Rivas-FuentesSilvia Guzmán-BeltránAngélica Flores-FloresJorge Rosas-GarcíaTeresa Santos-Mendoza
Published in: Molecules (Basel, Switzerland) (2021)
PDZ (postsynaptic density (PSD95), discs large (Dlg), and zonula occludens (ZO-1)-dependent interactions are widely distributed within different cell types and regulate a variety of cellular processes. To date, some of these interactions have been identified as targets of small molecules or peptides, mainly related to central nervous system disorders and cancer. Recently, the knowledge of PDZ proteins and their interactions has been extended to various cell types of the immune system, suggesting that their targeting by viral pathogens may constitute an immune evasion mechanism that favors viral replication and dissemination. Thus, the pharmacological modulation of these interactions, either with small molecules or peptides, could help in the control of some immune-related diseases. Deeper structural and functional knowledge of this kind of protein-protein interactions, especially in immune cells, will uncover novel pharmacological targets for a diversity of clinical conditions.
Keyphrases
  • healthcare
  • single cell
  • randomized controlled trial
  • sars cov
  • cell therapy
  • cancer therapy
  • papillary thyroid
  • young adults
  • amino acid
  • mesenchymal stem cells
  • cerebrospinal fluid
  • bone marrow
  • lymph node metastasis